Optimal Duration of Fluorouracil-Based Adjuvant Chemotherapy for Patients with Resectable Gastric Cancer

• Jing-lei Qu,

  Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

  ⨯
• Xin Li,

  Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

  ⨯
• Xiu-juan Qu ,

  * E-mail: cmuliuyunpeng@hotmail.com (YPL); qu_xiujuan@hotmail.com (XJQ)

  Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

  ⨯
• Zhi-tu Zhu,

  Affiliation Department of Oncology, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, China

  ⨯
• Li-zhong Zhou,

  Affiliation Department of Medical Oncology, The Fourth Hospital of Anshan, Anshan, China

  ⨯
• Yue-e Teng,

  Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

  ⨯
• Jing-dong Zhang,

  Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

  ⨯
• Bo Jin,

  Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

  ⨯
• Ming-fang Zhao,

  Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

  ⨯
• Ping Yu,

  Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

  ⨯
• Yun-peng Liu

  * E-mail: cmuliuyunpeng@hotmail.com (YPL); qu_xiujuan@hotmail.com (XJQ)

  Affiliation Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

  ⨯